Vitamin D and K2 work as a pair. Vitamin D helps your body absorb calcium,* and K2 helps direct where that calcium ends up.* That's why many of the better supplements include both.
Do you strictly need them together? No. But once you see what each one does, pairing them makes obvious sense. It's why D3X includes K2 as MK-7 in every dose.
Here's the logic, and the research behind it.
WHAT EACH ONE DOES
Vitamin D's job in this story is calcium. It helps your body absorb calcium from your diet.* More vitamin D means more calcium pulled into the bloodstream.
But absorbing calcium is only half the problem. Where it goes matters just as much. You want it in your bones, not collecting in soft tissue like your arteries. That routing job is where K2 comes in.*
HOW K2 ROUTES CALCIUM
K2 activates two proteins that manage calcium. Osteocalcin binds calcium into the bone matrix.* Matrix Gla protein helps keep calcium out of soft tissue like artery walls.* Researchers sometimes call the gap between absorbing calcium and placing it correctly the "calcium paradox," and K2 is the nutrient tied to closing it.*
This isn't fringe. A 2020 review in Nutrients lays out how MK-7, the long-chain form of K2, activates these proteins, and why its longer half-life makes it well suited to once-a-day use.
WHAT THE RESEARCH ACTUALLY SHOWS
The evidence breaks into two parts: the mechanism and the clinical outcomes.
The mechanism is solid. K2 carboxylates osteocalcin, and carboxylated osteocalcin is what binds calcium to bone.* The clinical outcomes are less uniform. A 3-year trial in Osteoporosis International gave 244 healthy postmenopausal women 180 mcg of MK-7 daily and found significantly less age-related decline in bone mineral density and bone strength than placebo.* A separate 3-year trial in the same journal gave 375 mcg to 142 women with osteopenia and saw osteocalcin carboxylation improve, but no measurable change in bone density.
Taken together: the biology is well established, one large trial showed a bone benefit,* and another moved the marker without moving density. Adding K2 to D3 is a reasonable, low-risk move with real research behind it.
WHICH FORM OF K2
If a supplement includes K2, the form matters. The two common ones are MK-4 and MK-7. MK-7 has higher bioavailability and a much longer half-life, which makes it the better fit for a once-daily habit. D3X uses K2 as MK-7.
THE BOTTOM LINE
You can take vitamin D on its own. But D3 increases how much calcium your body absorbs,* and K2 helps make sure that calcium ends up in the right place,* so the two are a natural pair. If you're already taking D3 every day, adding K2 is a low-cost, well-reasoned move. D3X just builds it in, so you don't have to think about it.
D3 brings the calcium in. K2 helps put it where it belongs.
Sources
NIH Office of Dietary Supplements. "Vitamin D: Fact Sheet for Consumers." 2025.
"MK-7 and Its Effects on Bone Quality and Strength." Nutrients, 2020.
Knapen MH, et al. "Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women." Osteoporosis International, 2013.
"The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia: a 3-year randomized, placebo-controlled clinical trial." Osteoporosis International, 2020.
Frequently Asked
Do you need to take K2 with vitamin D?
You don't strictly need to, but the two work as a pair: vitamin D helps your body absorb calcium,* and K2 helps direct where that calcium goes.* Many quality supplements include both for that reason.
What does vitamin K2 do?
K2 activates proteins that manage calcium: osteocalcin, which binds calcium into the bone matrix,* and matrix Gla protein, which helps keep calcium out of soft tissue like arteries.* That role is why K2 is often paired with vitamin D.
Is MK-7 or MK-4 the better form of K2?
MK-7 has higher bioavailability and a much longer half-life than MK-4, which makes it better suited to once-daily supplements. D3X uses K2 as MK-7.
Does taking K2 with vitamin D support bone health?
The mechanism is well established: K2 helps carboxylate osteocalcin, which binds calcium to bone.* Clinical results are mixed. One 3-year trial of 180 mcg MK-7 found less bone-density decline in postmenopausal women,* while another found the marker improved without a density change. The pairing is low-risk and biologically reasonable.